1Bobryshev YV, Bobryshev YV, Lord RS, et al. Structural peculiarities of vascular dendritic cell tubulovesicular system in human atherosclerotic aorta[ J ]. J Submicrosc Cytol Pathol, 1997, 29 ( 4 ):553-561.
2Bobryshev YV, Watanabe T. Ultrastructural evidence for association of vascular dendritic cells with T-lymphocytes and with B-cells in human atherosclerosis [ J ]. J Submicrosc Cytol Pathol, 1997,29(2): 209-221.
3Bobryshev YV, Lord RS. Detection of vascular dendritic cells accumulating calcified deposits in their cytoplasm [ J ]. Tissue Cell,1998, 30(3) :383-388.
4Bobryshev YV, Babaev VR, Lord RS, et al. Ultrastructural identification of cells with dendritic cell appearance in atheroclerotic aorta of apolipoprotein E deficient mice[ J ]. J Submicrosc Cytol Pathol,1999,31(4): 527-531.
5Bobryshev YV, Taksir T, Lord RS, et al. Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice [ J ]. Histol Histopathol, 2001,16: 801-808.
6Malkiel S, Factor S, Diamond B. Autoimmune myocarditis does not require B cells for antigen presentation[ J]. J Immunol, 1999,163:5265-5268.
7Izumi T, Takehana H, Matsuda C, et al. Experimental autoimmune myocarditis and its pathomechanism [ J ]. Herz,2000,25 ( 3 ): 274-278.
8Ratcliffe NR, Wegmann KW, Zhao RW, et al. Identification and characterization of the antigen presenting cell in rat autoimmune myocarditis: evidence of bone marrow derivation and non-requirement for MHC class Ⅰ compatibility with pathogenic T cells[J]. J Autoimmun ,2000,15:369-379.
9Shioji K, Kishimoto C, Sasayama S. Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of expression of dendritic cells[J]. Circ Res,2001,89:540-548.
10Khanna A, Steptoe R J, Antonysamy MA, et al. Donor bone marrow potentiates the effect of tacrolinus on nonvascularized heart allograft surrival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow[J]. Transplantation,1998,65 (4) :479-485.
